 Connection
Ashley Brooks-Russell to Hallucinogens
This is a "connection" page, showing publications Ashley Brooks-Russell has written about Hallucinogens.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.846 |
|
|
|
-
Wang GS, Kosnett M, Subramanian P, Wrobel J, Ma M, Brown T, Bidwell LC, Brooks-Russell A. Accuracy and replicability of identifying eyelid tremor as an indicator of recent cannabis smoking. Clin Toxicol (Phila). 2024 Jan; 62(1):10-18.
Score: 0.777
-
Kosnett MJ, Ma M, Dooley G, Wang GS, Friedman K, Brown T, Henthorn TK, Brooks-Russell A. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):355-362.
Score: 0.734
-
Rague JM, Ma M, Dooley G, Wang GS, Friedman K, Henthorn TK, Brooks-Russell A, Kosnett MJ. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):363-369.
Score: 0.182
-
Karoly HC, Milburn MA, Brooks-Russell A, Brown M, Streufert J, Bryan AD, Lovrich NP, DeJong W, Cinnamon Bidwell L. Effects of High-Potency Cannabis on Psychomotor Performance in Frequent Cannabis Users. Cannabis Cannabinoid Res. 2022 02; 7(1):107-115.
Score: 0.153
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|